Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Billy R Martin

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2002
Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivoRobert J McKallip, Catherine Lombard, Billy R Martin, et al.
Molecular Pharmacology|August 3, 2004
Long-term administration of Delta9-tetrahydrocannabinol desensitizes CB1-, adenosine A1-, and GABAB-mediated inhibition of adenylyl cyclase in mouse cerebellumDana E Selley, Michael P Cassidy, Billy R Martin, et al.
Bioorganic & Medicinal Chemistry|December 3, 2005
Synthesis and pharmacology of 11-nor-1-methoxy-9-hydroxyhexahydrocannabinols and 11-nor-1-deoxy-9-hydroxyhexahydrocannabinols: new selective ligands for the cannabinoid CB2 receptorKarla-Sue C Marriott, John W Huffman, Jenny L Wiley, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2007
The role of fluorine substitution in the structure-activity relationships (SAR) of classical cannabinoidsPeter J Crocker, Anu Mahadevan, Jenny L Wiley, et al.
Bioorganic & Medicinal Chemistry|February 21, 2012
Synthesis and pharmacology of 1-alkyl-3-(1-naphthoyl)indoles: steric and electronic effects of 4- and 8-halogenated naphthoyl substituentsJenny L Wiley, Valerie J Smith, Jianhong Chen, et al.
Pharmacology, Biochemistry, and Behavior|August 29, 2006
SR 141716 (Rimonabant) precipitates withdrawal in marijuana-dependent miceDavid M Wilson, Stephan A Varvel, John P Harloe, et al.
Neuropharmacology|July 22, 2009
Characterization of pharmacological and behavioral differences to nicotine in C57Bl/6 and DBA/2 miceKia J Jackson, Carrie L Walters, Michael F Miles, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
3-(4-Aminobutyn-1-yl)pyridines: binding at alpha 4 beta 2 nicotinic cholinergic receptorsDeniz Dogruer, Mase Lee, Malgorzata Dukat, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|February 6, 2008
The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptorErinn S Raborn, Francine Marciano-Cabral, Nancy E Buckley, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2006
1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: new high affinity ligands for the cannabinoid CB1 and CB2 receptorsJohn W Huffman, Lea W Padgett, Matthew L Isherwood, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2002
Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivoRobert J McKallip, Catherine Lombard, Billy R Martin, et al.
Molecular Pharmacology|August 3, 2004
Long-term administration of Delta9-tetrahydrocannabinol desensitizes CB1-, adenosine A1-, and GABAB-mediated inhibition of adenylyl cyclase in mouse cerebellumDana E Selley, Michael P Cassidy, Billy R Martin, et al.
Bioorganic & Medicinal Chemistry|December 3, 2005
Synthesis and pharmacology of 11-nor-1-methoxy-9-hydroxyhexahydrocannabinols and 11-nor-1-deoxy-9-hydroxyhexahydrocannabinols: new selective ligands for the cannabinoid CB2 receptorKarla-Sue C Marriott, John W Huffman, Jenny L Wiley, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2007
The role of fluorine substitution in the structure-activity relationships (SAR) of classical cannabinoidsPeter J Crocker, Anu Mahadevan, Jenny L Wiley, et al.
Bioorganic & Medicinal Chemistry|February 21, 2012
Synthesis and pharmacology of 1-alkyl-3-(1-naphthoyl)indoles: steric and electronic effects of 4- and 8-halogenated naphthoyl substituentsJenny L Wiley, Valerie J Smith, Jianhong Chen, et al.
Pharmacology, Biochemistry, and Behavior|August 29, 2006
SR 141716 (Rimonabant) precipitates withdrawal in marijuana-dependent miceDavid M Wilson, Stephan A Varvel, John P Harloe, et al.
Neuropharmacology|July 22, 2009
Characterization of pharmacological and behavioral differences to nicotine in C57Bl/6 and DBA/2 miceKia J Jackson, Carrie L Walters, Michael F Miles, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
3-(4-Aminobutyn-1-yl)pyridines: binding at alpha 4 beta 2 nicotinic cholinergic receptorsDeniz Dogruer, Mase Lee, Malgorzata Dukat, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|February 6, 2008
The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptorErinn S Raborn, Francine Marciano-Cabral, Nancy E Buckley, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2006
1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: new high affinity ligands for the cannabinoid CB1 and CB2 receptorsJohn W Huffman, Lea W Padgett, Matthew L Isherwood, et al.
Pageof 11